CAJ | 학술논문

目的探讨CT引导下计算机三维治疗计划系统(TPS)术中实时治疗计划在125 Ⅰ粒子植入治疗胸部肿瘤中应用的必要性和可行性.方法对2010-2012年间31例行125Ⅰ粒子治疗的胸部肿瘤患者资料进行回顾分析,其中13例术中行TPS实时计划优化(A组),余18例未行术中实时计划(B组).按经验间隔1 cm植入粒子,所有患者处方剂量110 Gy,术后均行TPS质量验证.并在B组原术中影像资料上重新模拟实时计划(C组),比较各组质量验证满意率.采用x2检验差异.结果 A、B组术后质量验证满意率分别为92％、39％ (P=0.003),C组重新模拟计划后满意率为94％,也高于B组(P=0.001),但与A组相似(P=0.811).结论术中实时治疗计划在CT引导下125Ⅰ粒子治疗胸部肿瘤可显著提高肿瘤靶区剂量满意率,具有可操作性,对胸部肿瘤粒子治疗的规范化具有重要价值.
목적 탐토CT인도하계산궤삼유치료계화계통(TPS)술중실시치료계화재125 Ⅰ입자식입치료흉부종류중응용적필요성화가행성.방법 대2010-2012년간31례행125Ⅰ입자치료적흉부종류환자자료진행회고분석,기중13례술중행TPS실시계화우화(A조),여18례미행술중실시계화(B조).안경험간격1 cm식입입자,소유환자처방제량110 Gy,술후균행TPS질량험증.병재B조원술중영상자료상중신모의실시계화(C조),비교각조질량험증만의솔.채용x2검험차이.결과 A、B조술후질량험증만의솔분별위92％、39％ (P=0.003),C조중신모의계화후만의솔위94％,야고우B조(P=0.001),단여A조상사(P=0.811).결론 술중실시치료계화재CT인도하125Ⅰ입자치료흉부종류가현저제고종류파구제량만의솔,구유가조작성,대흉부종류입자치료적규범화구유중요개치.
Objective To explore the necessity and feasibility of the real-time treatment planning optimization by CT guided with 125Ⅰ seed implantation brachytherapy treatment to thoracic malignancies.Methods To retrospectively analyze the data of 31 inpatients (from October 2010 to June 2012) with thoracic malignancie by CT guidance 125Ⅰ brachytherapy.The real-time planning optimization were applicated to 13 cases (group A),18 patients undergoing experience particles implantation interval 1 cm (group B),all the patients were prescribed dose 110 Gy and post-planning verified after surgery.Re-simulation of realtime program (group C) about the image data in group B,data analysis was x2-test by SPSS 13.0 software.Results The quality verification in two groups were 92％ and 39％,the difference was statistically sifnificant (P =0.003).The re-simulation program in group C was 94％,there was significant difference compared with group B (P =0.001),but with no significant difference compared with group A (P =0.811).Conclusions The application of intraoperative real-time planning by CT guided with 125Ⅰ seed implantation brachytherapy to thoracic malignancies,non-equidistant layout that be the real implantedneedle trajectory based on dosimetry,can significantly improve the tumor target dose,operational,there was greatly important value to the standardization of the particle therapy of thoracic malignancies.